Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial)Antonio Avallone, Alfredo Budillon, Paolo Delrio et al.|BMC Cancer|2014Cited by 41